Short-term exposure to ozone in relation to mortality and out-of-hospital cardiac arrest : exploring sensitive subgroups by previous hospitalizations by Raza, Auriba
Thesis for doctoral degree (Ph.D.)
2018
Short-term exposure to ozone in relation to  
mortality and out-of-hospital cardiac arrest 
Exploring sensitive subgroups by previous hospitalizations
Auriba Raza
A
uriba Raza
Short-term
 exposure to ozone in relation to m
ortality and out-of-hospital cardiac arrest 
Exploring sensitive subgroups by previous hospitalizations
From Institute of Environmental Medicine 
Karolinska Institutet, Stockholm, Sweden 
SHORT-TERM EXPOSURE TO OZONE IN 
RELATION TO MORTALITY AND OUT-OF-
HOSPITAL CARDIAC ARREST: 
EXPLORING SENSITIVE SUBGROUPS BY 
PREVIOUS HOSPITALIZATIONS 
Auriba Raza 
 
Stockholm 2018 
 
  
All previously published papers were reproduced with permission from the publisher. 
Published by Karolinska Institutet. 
Printed by Eprint AB 2018 
© Auriba Raza, 2018 
ISBN 978-91-7676-874 -7 
Short-term exposure to ozone in relation to mortality and 
out-of-hospital cardiac arrest: Exploring sensitive 
subgroups by previous hospitalizations 
 
THESIS FOR DOCTORAL DEGREE (Ph.D.) 
By 
Auriba Raza 
Principal Supervisor: 
Petter Ljungman 
Karolinska Institutet 
Institute of Environmental Medicine 
Division of Environmental Epidemiology 
 
Co-supervisor: 
Tom Bellander 
Karolinska Institutet 
Institute of Environmental Medicine 
Division of Environmental Epidemiology 
 
 
Opponent: 
Ole Hertel 
Aarhus University 
Department of Environmental Science –  
Atmospheric chemistry and physics 
 
Examination Board: 
Martin Holzmann 
Karolinska Institutet 
Department of Emergency Medicine 
 
Hans-Christen Hansson 
Stockholm University 
Department of Environmental Science and 
Analytical Chemistry 
 
Hans Persson 
Danderyd Hospital   
Department of Clinical Sciences 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
I dedicate this thesis to my parents, who made it possible with their relentless and dedicated 
efforts throughout my life; to my husband, Shahid Raza, for motivating me to pursue doctoral 
education and for his guidance and persistent support; and to my sons, Azan and 
Muhammad, my ultimate source of pride and joy. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strive always to excel in virtue and truth 
The Last Prophet (peace be upon him)
  
ABSTRACT 
Background: Several epidemiological studies have associated short-term ozone (O3) exposure 
with mortality, as well as with out-of-hospital cardiac arrest (OHCA) and other morbidity. 
Knowledge on which parts of the general population that are susceptible to adverse O3-related 
health effects is scarce.  
Aim: The aim of this thesis is to explore the role of previous disease in conferring 
susceptibility to O3 exposure in relation to total, cardiovascular and respiratory mortality, and 
OHCA.   
Materials and Methods: We obtained information on age, sex, date and cause of death 
[classified using the International Classification of Diseases, Ninth (ICD-9) and Tenth 
Revision (ICD-10)] on all non-traumatic deaths that occurred in Stockholm County from 
1990 to 2010. We considered all non-traumatic deaths, as well as cardiovascular and 
respiratory deaths separately. Data on all Emergency Medical Service-assessed OHCA were 
obtained from the Swedish Register for Cardiopulmonary Resuscitation. We included all 
OHCAs that occurred in Stockholm County from 2000 to 2014, and all OHCA occurring in 
2006-2014 in Gothenburg and Malmö. All deaths and OHCA were linked to their previous 
hospitalizations as recorded in the National Patient Register, using personal identification 
numbers. Hourly values of O3 were obtained from single urban background monitoring 
stations in each city. We generated daily 8-h maximum levels as well as 2-h, 24-h, 2d, and 7d 
means. The associations between ambient O3 levels and health outcomes were estimated with 
time-series analyses using generalized additive and linear models, and with time-stratified 
case-crossover analysis. 
Results: Short-term increases in O3 levels were associated with increased risks of total, 
cardiovascular and respiratory mortality, irrespective of previous hospitalizations. Individuals 
previously hospitalized for myocardial infarction demonstrated a higher O3-related risk of 
total and cardiovascular mortality in comparison with the general population (1.7 % vs 0.5 %; 
2.1 % vs 0.8 %, per 10 µg/m3 increase in O3 during a 2d period). Individuals with previous 
hospitalization for chronic obstructive pulmonary disease exhibited higher risk of O3-related 
respiratory mortality compared to the general population (5.5 % vs 2.7 %). Furthermore, O3 
exposure was associated with OHCA. A 10 µg/m3 increase of 2-h and 24-h averaged O3 was 
associated with an odds-ratio of 1.02 (95% CI: 1.01, 1.05) and 1.04 (95% CI: 1.01 – 1.07), 
respectively. We did not however observe a difference in O3-related risk of OHCA in 
individuals hospitalized for any of the pre-specified diagnoses of acute myocardial infarction, 
heart failure, diabetes, hypertension, or stroke, in comparison with the general population.  
Conclusions: Our results suggest that previous hospitalizations for myocardial infarction or 
chronic obstructive pulmonary disease increases the susceptibility for mortality following 
short-term exposure to O3. In contrast, previous hospitalizations for cardiovascular diseases 
did not seem to modify the associations between short-term increases in O3 levels and the risk 
out-of-hospital cardiac arrest. 
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1 INTRODUCTION 
Air pollution is a major environmental threat to human health, and now ranks amongst the top 
global health risk burdens. A systematic analysis of major global health risks concluded that 
fine particulate matter pollution account for >3 million premature deaths globally and over 74 
million years of healthy life lost. The main causes of air pollution-related mortality are 
cerebrovascular disease that accounted for 1.31 million deaths and ischemic heart disease that 
lead to 1.08 million deaths. This underlines that the vast majority of air pollution deaths are 
due to cardiovascular diseases [1]. The American Heart Association scientific statements in 
2004 and 2010 provided several lines of evidence on the causal relationship between 
exposure to particulate matter and cardiovascular morbidity and mortality [2]. Cardiovascular 
disease is also a leading cause of mortality in Europe and North America. It is responsible for 
over 4 million deaths per year in Europe which is almost half the total mortality rate [3]. In 
Sweden, about 3,500 premature deaths per year are related to particulate matter air pollution. 
[4]. Ozone (O3) exposure has also recently received attention as an emerging threat.  
1.1 AIR POLLUTION IN GENERAL  
Air pollution is defined as a complex mixture of gases, liquids and solid particles suspended 
in air at levels that pose risk to human health. These chemical compounds are called air 
pollutants and are broadly classified into particles and gases. Particles are classified according 
to the size of their aerodynamic diameter expressed as particulate matter equal to or less than 
10 micrometers in diameter (PM10), fine particles (PM2.5), coarse particles (PM10 – PM2.5), 
and ultrafine particles (PM0.1). Gases generally include nitric oxide (NO), nitrogen dioxide 
(NO2), carbon monoxide (CO), sulphur dioxide (SO2), and O3. Household combustion, 
traffic, industrial processes and forest fires are common sources of these air pollutants. 
Pollutants of major public health concern are particulate matter, CO, O3, NO2, and SO2. In our 
study setting we have very lows levels of air pollution except for O3 and it is the only 
pollutant we observed associations with. Therefore, the focus of this thesis is on susceptibility 
to the adverse effects of O3.  
1.2 OZONE  
Ozone is a highly reactive oxidant gas which in the stratosphere (10-16 kilometres above 
Earth’s surface) acts as a protective shield against the harmful ultraviolet radiations emitted 
by the sun. However, O3 close to Earth’s surface is an air pollutant and is associated with 
multitude of health effects [5]. 
1.2.1 Ozone Formation 
Ground-level O3 is a secondary air pollutant formed at ground level by complex chemical 
reactions involving precursor compounds, such as nitrogen oxides and hydrocarbons, in the 
presence of sunlight. Formation of O3 requires a free oxygen atom (O) that may be provided 
by the dissociation of nitrogen dioxide (NO2) in the presence of sunlight.  
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NO2 + hν (λ < 420 nm) → O+ NO 
The free oxygen atom and nitrogen oxide (NO) then react with molecular oxygen (O2) and 
produce O3. M is a non-reactive molecule that takes up the energy released in the reaction.  
O + O2 + M → O3 + M 
In the presence of NO O3 reacts with NO and forms NO2 
O3 + NO → O2 + NO2 
In a closed system, these reactions thus merely recycle O3 and NOx and do not result in net 
production of O3. Net O3 production occurs in the presence of other precursors such as carbon 
monoxide (CO), methane (CH4), non-methane hydrocarbons (NMHC), or certain other 
volatile organic compounds (VOC). Ambient O3 concentrations formed by these chemical 
compounds are directly influenced by temperature, solar radiation, wind speed, and other 
meteorological factors. A simplified schematic pattern of O3 formation is presented in Figure 
1.1.  
 
Figure 1.1 Ozone Formation 
Close to combustion sources, the background O3 is reduced by directly emitted NO to form 
NO2, while away from the source and in the presence of sufficient VOCs and under 
favorable weather conditions NOx emissions lead to rise in O3 concentrations [6].  
1.2.2 Precursors and Ozone Transport 
Nitrogen oxides can be transported to remote areas as a reservoir species, such as peroxy-
acetyl nitrates (PANs). These are a significant source of NOx, and together with naturally 
released biogenic VOCs, form O3 in non-polluted areas [6]. Ozone can also be transported 
to areas far away from where it originally formed and even across continents [7]. Some of 
the O3 measured in Europe has its origins in North America and Asia [7, 8]. At times 
stratospheric O3 descends down to ground level, resulting in comparatively high 
concentrations also in the absence of O3 formation at ground level, particularly in remote 
unpolluted areas [9]. 
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1.2.3 Spatial and Temporal Variability 
Background O3 levels have large spatial and temporal variability. Variations in O3 
concentrations are driven by the changes in the balance of its chemical productions and loss 
processes as air mass moves to and from different locations [9]. This balance is highly 
sensitive to the level of sunlight in a region [9]. Levels are generally high in the vicinity of 
urban environments where precursor emissions are high. Ozone levels increase with 
increased VOCs levels and intense sunlight but NOx emissions affect both formation and 
destruction of O3. In trafficated environments O3 levels are low due to NO emissions which 
consume O3. In rural areas close to precursor emissions O3 concentration is higher due to lack 
of O3 predators such as NO. Some areas are also influenced by the transport of air masses 
containing precursor emissions and additional biogenic VOCs emissions that further increase 
O3 levels.  
Ozone exhibits typical diurnal variability with higher levels during afternoon when 
photochemical activity is intense. The formation during the day is also driven by higher 
precursor emissions. Ozone has clear seasonal patterns with higher levels during the summer 
months when there is more sunlight.  
1.2.4 Relationship Between Ozone Precursors and Ozone Concentrations 
Since 1980s anthropogenic O3 precursor emissions have reduced significantly in European 
countries but have not resulted in equivalent reductions in O3 levels [6]. This is attributed to 
increased intercontinental transport ofO3 and its precursors [10] showing that trends in 
European O3 levels cannot be entirely explained by changes in European precursor emissions. 
Increase in the levels of background O3 along the Atlantic borders of Europe is influenced 
by the increased NOx emissions in North America and Asia [11]. Furthermore, reductions 
in European NOx emissions lead to low NO concentrations resulting in increased O3 levels 
in urban environments in southern, central, and north-western parts of Europe [12, 13]. 
Other factors likely to mask the effects of European measures to reduce anthropogenic O3 
precursor emissions are climate variability, non-methane VOCs emissions from vegetation , 
and fire plumes from biomass and forest fires [14].  
In Sweden, the situation is equally complicated. High O3 levels have been observed at 
Esrange, in the northern part of Sweden. This area is far from pollution source areas and 
indicates the influence of long-range transport of O3 [15, 16] and the contribution of 
stratospheric O3 [17]. Ozone coming to Stockholm is mostly transported by the air 
originating from southeast of Europe, particularly during the summer months (Figure 1.2) 
[18]. There is some local formation of O3 during spring and summer but is relatively small 
and slow due to less days with high temperatures and is least likely to affect Sweden’s 
summer O3 levels. Polluted air masses containing NOx emissions from European and 
regional sources and with additional local sources of NOx emissions act as a temporary sink 
for O3 during winter in stable weather conditions [15]. 
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Figure 1.2 Monthly median concentrations of 8-h maximum O3 concentrations in the four 
trajectory sectors with origin at Aspvreten (SW: Southwest; SE: Southeast; NW: 
Northwest; NE: Northeast) averaged over all available data in the period 1997-2010. 
Vertical bars are 75 and 25 percentiles. Source: Jönsson O, et al Boreal environment 
research. 2013;18(3-4):280-302.    
1.2.5 Air Quality Guidelines 
The World Health Organization (WHO) published its first air quality guidelines (AQG) in 
1987 based on scientific evidence. Most high-income countries have considerably reduced 
their air pollution levels since then [19, 20]. Total emissions of O3 precursor gases (NOx, SO2, 
and non-methane VOCs) in Europe reduced by 29% between 1990 and 2000 [19] and a 
decline in particulate matter and its precursors has also been observed [19]. However, since 
2000 the air quality in Sweden and elsewhere in Europe has improved more discretely [21]. 
Presently, the air pollution levels in many traffic environments are still high, both in Sweden 
and elsewhere in Europe [21]. Large percentages of the EU urban population are exposed to 
levels exceeding the current WHO AQG value [22] of 100 µg/m3 (as a daily 8-h maximum) 
for O3 (O3, 95%) [20] (Table 1.1). Ozone levels, however, remained below the WHO AQG in 
Sweden during the last decade. Despite this, current levels of O3 have been associated with 
adverse health outcomes even at levels below the AQG in Sweden and other countries [23, 
24] and there is no evidence at this stage to support a threshold below which no health effects 
are expected [25]. Indeed it has been suggested that the exposure response relationship 
strengthens at lower levels [25]. 
Table 1.1 Ambient air quality standard for daily 8-h maximum average of O3 
levels in µg/m3 by WHO (Air Quality Guideline 2005), EU-directive, and the 
US environmental protection agency.  
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1.2.6 Population Exposure  
Studies of short-term health effects of ambient air pollution commonly employ two different 
exposure assessment strategies. For smaller panel studies, exposure may be assessed through 
personal monitoring. This requires that participants are able to carry portable monitoring 
equipment for a specified time period. While this may provide more precise personal 
exposure it has several drawbacks: It necessitates a selection of participants able and willing 
to wear the equipment, it measures outdoor and as well as indoors sources with some 
difficulty of separation, it limits the time-frame and sample size of exposure assessment and 
is costly and logistically challenging. Large studies of rare events such as mortality or 
hospital admissions are not amenable to this strategy and instead make use of time-series of 
continuous exposure measurements from strategically located fixed monitoring stations. 
Typically, studies use monitors situated at roof-tops or similar, capturing the average urban 
background level. In an urban environment, the temporal variability of O3 over a period of 
hours to a few weeks is generally large in comparison with the variability in the spatial 
gradient, even over a large urban fabric. Owing to the comparatively smooth spatial 
distribution of O3, these monitors therefore capture the relative temporal changes in ambient 
O3 levels for a large geographical area. Apart from temporal and spatial variability of ambient 
O3, indoor O3 levels are substantially lower than outdoor levels. However, the overwhelming 
majority of the subsequently discussed studies have employed centrally located roof-level 
monitors reflecting urban background levels to assess O3 exposure.  
1.3 HEALTH EFFECTS OF OZONE EXPOSURE 
1.3.1 Mortality 
Positive associations between short-term exposure to O3 and all-cause mortality were 
consistently observed in recent multicity time-series studies, conducted in several European 
[26, 27], in 80 US cities [28], and a multi-continental study [29]. These studies reported 
higher risk estimates for mortality stratified by warm or summer seasons. In relation to cause-
specific mortality, O3 exposure has been associated in many studies with respiratory mortality 
including the Air Pollution and Health: a European and North American Approach 
(APHENA) study [30] and other large multicity studies from the U.S [31], Europe [32], Italy 
[33], and Asia [34]. Furthermore, studies demonstrated positive associations for 
cardiovascular mortality in single pollutant, all year, and summer season analyses, also in 
multipollutant models including PM10 [30-33]. However, in the APHENA study 
cardiovascular mortality risk estimates in U.S. and Canadian datasets were sensitive to the 
inclusion of PM10 in the model [30].  
1.3.2 Morbidity 
1.3.2.1 Cardiac arrest 
Cardiac arrest is a leading cause of cardiovascular death and in Sweden about 10,000 cardiac 
arrests occur annually with a 3-16% survival to one month [35]. Studies investigating the 
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association between transient air pollution exposure and the risk of out-of-hospital cardiac 
arrest (OHCA) have been conducted in the United States [36-40], Europe [41-43], Australia 
[44, 45], and Asia [46]. Studies from New York city [39], Indianapolis [38], and Houston 
[36] observed elevated risk of OHCA with increased levels of PM2.5 on the hour of or 1-3 
days before the cardiac arrest. The Houston study also found strong associations with O3 at 
very short time intervals within hours [36]. All the US studies used daily averages as their 
exposure metric except the Houston study that used hourly means. A study from Helsinki, 
Finland reported O3 exposure associated with increased risk of OHCA of cardiac origin other 
than AMI in 1 and 2 day lag, no association was reported for hourly lags [41]. A study 
conducted in Copenhagen, Denmark did not observe O3 exposure with OHCA, however, 
reported fractions of particulate matter associated with OHCA at lag 3 and 4 day [42]. Large 
studies from Melbourne [44] and Perth [45], Australia observed strong associations with 
PM2.5, however, no effect was observed with O3. The study from Melbourne used daily 
averages for exposure windows and the study from Perth used hourly means. Furthermore, a 
study from Okayama, Japan reported associations with O3 for 72-96 hours lags and 48 to 72 
hours for PM2.5  [47]. In Beijing, China with high air pollution levels a study used daily 
averages and observed strong associations between PM2.5 at lag day-1 and cardiac arrest, 
while no associations were observed with O3. [48]. A study from Seoul, South Korea, did not 
observe association with O3 in any lags, however, reported association between PM2.5 
exposure and OHCA [49].  
1.3.2.2 Other morbidities 
Other observed adverse health effects of O3 include changes in pro-arrhythmic measures, for 
instance decreased heart rate variability [50], association with ventricular arrhythmias in 
patients with implantable cardioverter defibrillators [51, 52], reduced lung capacity in 
children and adults [53, 54], increased risk of COPD-related emergency and hospital 
admissions [55, 56], increased risk of myocardial infarction [57], and increased emergency 
department visits for cardiovascular and respiratory diseases [58].  
1.4 SUSCEPTIBLE POPULATIONS 
There may be susceptible groups in general populations which are at higher risk of mortality 
or OHCA and might carry a major burden of negative effects of O3 exposure.  
1.4.1 Based on Individual Characteristics 
Individual characteristics may plausibly increase susceptibility to mortality following O3 
exposure. Studies investigating sex differences related to O3, NO2, SO2, and particulate 
matter (PM) exposure provided inconsistent findings [33, 59, 60]. Some studies observed 
higher susceptibility in women  [33, 61] while other reported no sex differences [62, 63].  
Aging processes are generally expected to contribute to an increased vulnerability of elderly 
people for environmental changes [64]. Elderly [23, 33, 65, 66] have thus been consistently 
reported as a high-risk group for the adverse effects of air pollution. Studies of other 
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pollutants than O3 have reported increased risk of death in individuals ≥ 65 years of age as 
compared to younger age group on exposure to PM, NO2, and SO2 [59] and increased risk of 
out-of-hospital coronary deaths in both 65-74- and 75+-yr age groups exposed to PM [67]. A 
recent meta-analysis of O3 and mortality reported higher risks in older as compared to the 
younger population [68]. Studies from Italy [33, 69] and US [70] also reported higher O3-
related mortality among elderly.   
1.4.2 Based on Existing Diseases 
Previous diseases might play an important role in individuals’ susceptibility towards O3-
related risks of mortality or OHCA. Several studies have investigated O3 exposure and total 
and cardiorespiratory mortality [27, 29, 71, 72], OHCA [73-76], and other morbidities [5, 77-
81], but studies focusing on risks based on individuals’ previous diseases are rare. In one 
study secondary causes of death were used as surrogates for previous diseases [70] and in two 
other studies previous disease histories were used [33, 69]. Pre-existing diseases that 
conferred increased susceptibility in these studies were not fully consistent from study to 
study but centered around diabetes, atrial fibrillation and atherosclerotic diseases [33, 69, 70]. 
Furthermore, no study investigated the effect modification of previous disease on the risk of 
OHCA following O3 exposure, however, previous disease history for diabetes, hypertension, 
and stroke [48, 49] have been reported to confer susceptibility to PM2.5-related risk of OHCA. 
1.5 GAPS 
Several studies have consistently associated O3 exposure with total and cardiovascular 
mortality while results on respiratory mortality have been inconsistent and a majority of 
studies were limited to the warm season. At the time we planned our study projects, there 
were few studies [44, 82-85] that examined associations between air pollution and OHCA 
and none of them investigated the effects of O3 exposure on OHCA. Existing OHCA studies 
used small data sets and daily averages for exposure, which carries a risk of exposure 
misclassification. There was a lack of knowledge on effects of exposure with short-temporal 
resolution on OHCA. Furthermore, higher susceptibility to harmful effects of air pollution 
among groups of individuals with pre-existing disease was rarely addressed. Existing studies 
have not considered cause-specific mortality, have been conducted in high pollution 
environments and have used secondary diagnoses or have not had access to full coverage 
patient and death registries. Knowledge on susceptible populations is important to provide 
relevant guidelines for air quality standards protecting significant susceptible groups within 
the general population in a low pollution setting. 
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2 AIMS 
The overall aim was to investigate acute risks of mortality and cardiac arrest associated with 
O3 exposure, and whether such risks are modified by previous disease manifestations. 
Specific aims were: 
• To estimate associations between short-term exposure to ambient O3, and total, 
cardiovascular, and respiratory mortality 
• To assess the role of previous hospitalizations in conferring susceptibility to O3-
related total, cardiovascular, and respiratory mortality 
• To examine the association between short-term exposure to ambient O3 and out-of-
hospital cardiac arrest 
• To assess the role of previous hospitalizations in conferring susceptibility to O3-
related risk of out-of-hospital cardiac arrest
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3 MATERIAL AND METHODS 
The first part of this sections summarizes outcome and exposure data with brief descriptions 
of their source and study populations along with time period of each study. Subsequently 
describe the statistical methods and analyses. Detailed descriptions are in the accompanying 
articles and manuscripts. 
3.1 OUTCOME AND EXPOSURE DATA 
3.1.1 Mortality 
Studies I and II considered mortality outcomes in Stockholm County.  We included all 
residents of Stockholm County who are older than 30 years of age and died in the County 
between 1990 and 2010. We obtained information on age, sex, date and cause of death 
[classified using the International Classification of Diseases, Ninth (ICD-9) and Tenth 
Revision (ICD-10)] from the Cause of Death Register [86]. For study I, we considered all 
non-traumatic deaths (ICD-9 codes 1–799; ICD-10 codes: A00-R99), while for study II, we 
considered cardiovascular (ICD-9 390-459, ICD-10 I00-I99) and respiratory (ICD-9 460-519, 
ICD-10 J00-J99) deaths separately.  
3.1.2 Out-of-Hospital Cardiac Arrests 
Studies III and IV considered out-of-hospital cardiac arrest as disease outcomes. All 
Emergency Medical Service (EMS)-assessed OHCA were obtained from the Swedish 
Register for Cardiopulmonary Resuscitation (SRCR). Cases are continuously registered in the 
SRCR if cardiopulmonary resuscitation (CPR) and/or defibrillation is attempted. The register 
also contained cardiac arrests where CPR was performed by a witness but not by the 
paramedics due to clear sign of death. From the register, we obtained information on gender, 
age, time and location of OHCA, status of patient when EMS-personnel arrived, and probable 
cause as evaluated by the EMS staff. Study III included all OHCA occurring in Stockholm 
County from 2000 to 2010. Study IV included all OHCA that occurred in Stockholm, 
Gothenburg and Malmö from 2006 to 2014. 
Inclusion criteria in both OHCA studies was based on etiology and the time of cardiac arrest 
(Figure 3.1). We only included cases that had been assessed as cardiac. In our dataset, we had 
33 time variables from three sources i) EMS-personnel, ii) police and iii) fire brigade. It was 
important to use a time closest to the actual time of OHCA as we used 2-hr exposure before 
the cardiac arrest and we did not want to include the exposure after the cardiac arrest in our 
case period. EMS-personnel are trained to record the time at each step of their response 
starting from the call to the arrival at the hospital, therefore, we used the time provided by the 
EMS-personnel. Moreover, to further avoid exposure temporal misclassification, we excluded 
cases that were dead (rigor mortis) when the EMS-personnel arrived. Cases with missing time 
data were also excluded. We used the time of cardiac arrest as the time dispatch center 
received the call or the communication between the ambulance and the emergency dispatch. 
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When this information was not available we used the time when ambulance arrived at the 
location of the event. 
 
Figure 3.1 Flow chart demonstrating inclusion of out-of-hospital cardiac arrest cases 
For Study IV, we also excluded cases for whom personal identification number was not 
available as personal identification numbers were required to link OHCA with their previous 
hospitalizations data. 
3.1.3 Previous Hospitalizations 
Data on all previous hospitalizations was obtained from The National Patient Register (NPR). 
Since 1987, NPR registers all in-patient care in Sweden and each hospitalization is linked to 
the personal identifications number. We obtained information on primary and secondary 
diagnosis, admission and discharge dates of previous hospitalization since 1987. We linked 
all deaths to previous hospitalizations to explore susceptibility to air pollution. We 
categorized individuals into different disease groups based on the principal diagnosis code 
(ICD-9 and ICD-10) at discharge.  
In study I, we used hospitalizations five years prior to death to explore potentially susceptible 
groups. Susceptibility was based on previous hospitalizations for all cardiovascular diseases 
(CVD; ICD-9 codes 390–459, ICD-10 codes I00–I99). We further categorized all CVD into 
previous hospitalizations for i) acute myocardial infarction (AMI; ICD-9 code 410, ICD-10 
codes I21 and I22); ii) heart failure (ICD-9 code 428, ICD-10 code I50); and ii) dysrhythmia 
(ICD-9 code 427, ICD-10 code I46–I49). Individuals with more than one hospitalization were 
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counted in different categories, thus, categories were not mutually exclusive. The temporal 
occurrences of previous hospitalizations with respect to successive death were grouped into 
three time intervals: 0–28 days, 29 days to 2 years, and 2 to 5 years before death. The same 
individual may have had different CVD diagnoses in each of the time intervals but 
contributed a maximum of one event for the same CVD diagnosis in each of the time interval.   
In study II, we explored potentially susceptible groups based on hospitalization occurring 
three years preceding death. Individuals who had a cardiovascular cause of death were 
characterized into groups based on previous hospitalizations for i) AMI (ICD-9 410, ICD-10 
I21-I22); ii), all other CVD (ICD-9 390-409, 411-459, ICD-10 I00-20, I23-99), excluding 
individuals with AMI; iii) respiratory diseases (ICD-9 460-519, ICD-10 J00-99), excluding 
individuals with prior hospitalizations for CVD; iv) diabetes (ICD-9 250, ICD-10 E10-14), 
excluding individuals with previous hospitalizations for CVD and respiratory diseases; v) 
other diseases, excluding individuals with CVD, respiratory diseases, and diabetes; vi) 
individuals with no hospitalization between 0-3 years before death for any disease but had 
earlier hospitalizations; and vii) individuals who had not been hospitalized since 1987. All 
previous hospitalization categories were mutually exclusive 
For respiratory deaths, we categorized individuals based on previous hospitalizations for i) 
COPD (ICD-9 490-496, ICD-10 J40-47, J67); ii) pneumonia (ICD-9 480-486, ICD-10 J12-
J18), excluding individuals with COPD; iii) other respiratory diseases (ICD-9 460-480, 486-
490, 497-519, ICD-10 J00-11, J19-40, J48-66, J68-99), excluding individuals with previous 
hospitalizations for COPD and pneumonia; iv) any disease other than respiratory disease; v) 
individuals with no hospitalizations between 0-3 years but had earlier hospitalizations and 
vii) individuals with no record of previous hospitalizations since 1987. All previous 
hospitalization categories were mutually exclusive. 
In Study IV, we naively explored whether previous hospitalization for any disease compared 
to no hospitalizations resulted in differences in associations between O3 and OHCA. We then 
created indicator variables for previous hospitalizations for i) AMI (ICD-9 410, ICD-10 I21-
I22); ii) heart failure (ICD-9 428, ICD-10 I50); iii) arrhythmias (ICD-9 426-427, ICD-10 I44- 
I49); iv) diabetes (ICD-9 250, ICD-10 E10-14); v) hypertension (ICD-9 401-405, ICD-10 
I10-I15); and vi) stroke (ICD-9 430-438, ICD-10 I60-68). These variables were not mutually 
exclusive.   
3.1.4 Air Pollution and Meteorological Parameters 
Air pollutants we investigated in our studies were O3, NO2, NOx, PM2.5, PM10, and coarse 
particles. Meteorological parameters used were temperature and relative humidity. All data 
on air pollutants, temperature and relative humidity for all studies was in hourly averages. 
Data for Stockholm County was obtained from a single urban background monitoring station 
located at Torkel Knutssonsgatan 20, approximately 20 m above ground-level, administered 
by Stockholm-Uppsala County Air Quality Management Associations. Measurements of 
NO2, NOX and O3 began in 1990, PM10 in 1994 and PM2.5 in the end of 1999. Therefore, in 
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studies I and II not all the pollutants are available throughout the study time period. Coarse 
particle fraction was calculated as the difference between PM10 and PM2.5. For study I and II, 
calendar day 24-hour averages for NO2, NOX, PM2.5 and PM10 were calculated. For O3 we 
first generated 8-hour running averages from the hourly observations and from that we 
calculated the 8-hour daily maximum. The 8-hour maximum O3 was missing on 8.3% of days 
during the study period and data was not imputed for the analysis. For the other pollutants, 
the missingness of 24-h averages range from 5.4 to 11.3% since measurements started. 
For Study III, we used data from Torkel Knutssonsgatan for all air pollutants. Additional O3 
data was provided by the Swedish Environmental Research Institute from a countryside 
station Aspvreten, 80 km southwest of Stockholm. Hourly values were used to calculate 
running means for exposure windows. Data on meteorological variables were obtained from 
suburban station, 50 m high meteorological mast, located in Högdalen.  
For study IV, air pollution and meteorological data for Gothenburg and Malmö was obtained 
from Department of Environment Management of both cities from 2006-2014. All the data 
was in hourly averages. Gothenburg’s measuring station is located at Femman, approximately 
25 m above the ground level. Measurements for PM2.5 were only available for the years 2007-
2010, while PM10 unavailable from October 2013 to the end of 2014 due to measuring 
problems with the instrument. The missingness of 2-h averages for PM2.5, PM10, NO2, NOx, 
and O3 was 46 %, 16 %, 2 %, 2 %, and 11 %, respectively. Measuring station at Malmö is 
located at Rådhuset, the missingness of 2-h averages for PM2.5, PM10, NO2, NOx, and O3 was 
4 %, 3 %, 1.8 %, 24 %, and 1 %, respectively. 
3.2 STATISTICAL METHODS AND ANALYSES 
3.2.1 Studies I and II 
3.2.1.1 Time-series  
We used time-series study design for studies I and II. This design is used to evaluate a 
relationship between an exposure and an outcome variable. Both exposure and outcome are 
aggregated over the same time units during a specific time period. This design is used to 
study short-term changes in the health outcome followed by transient changes in exposure. 
Behavioral variables or personal characteristics are not considered potential confounders as 
these factors would not be associated or change with the unit of temporal change in 
environmental exposures [87]. Only confounding variables in time-series design are those 
with short-term temporal variability associated with the exposure and the outcome. Important 
confounders in air pollution studies are meteorological variables like temperature, seasonal or 
periodic patterns or long-term trends of both exposure and outcome. Day of week and 
holidays are also potential confounders [87].    
Our studies were adjusted for seasonal patterns and long-term trends, relative humidity, 
temperature, daily influenza hospital admissions, public holidays and day of the week effect. 
In both studies I and II, day of the week and holidays were used as indicator variables. The 
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mean value of the relative humidity on the day of death and the preceding day before death 
(0-1 day) was modeled as a linear term and the mean value of the temperature during 0-1 day 
was modeled by cubic splines with 4 degrees of freedom (df) in study I, and in study II by 
restricted cubic splines with 2 df. In study I, a 7 day average of daily influenza admissions in 
Stockholm were modelled as a penalized spline with 4 df and as a restricted cubic spline with 
2 df in study II. In study II, long-term time trend was modeled as linear and quadratic 
functions of the day number throughout the study period and seasonal periodicity was 
modeled using sine and cosine terms with wavelengths of 3, 6, 12, and 36 months.  
3.2.1.2 Poisson regression 
In study I and II, we used Poisson regression to assess the associations between air pollutants 
and the risk of total, cardiovascular, and respiratory mortality in those with and without 
previous hospitalizations. Poisson regression is a statistical method frequently used to model 
count data. The response variable i.e. outcome is in the form of event counts for example 
number of deaths while the explanatory variable can be continuous or a combination of 
continuous and categorical variables.  
3.2.1.3 Statistical analyses 
For study I, we used 0-1 day averages for all pollutants and for O3 0-1 day average of 8-hr 
maximum was used. 
We first analyzed single pollutant models and then performed stratified analysis according to 
previous hospitalizations for the pollutants that demonstrated associations with total 
mortality. We also conducted an interaction analysis between the individuals with AMI and 
individuals without AMI but with other CVD. We then performed two-pollutants models. We 
also performed stratified analysis by i) age categorized as 30-70, 71-84, and 85+, ii) seasons 
categorized cold (October to March) and warm (April to September) season, and iii) sex.  
In study II, we used 0-1 and 0-6 day averages for all pollutants and for O3 same averages are 
used but were constructed from 8-hr maximum. For relative humidity and temperature, we 
used 0-1 day averages.  
We investigated associations between transient exposure to air pollution and cardiovascular 
mortality and respiratory mortality using lags 0-1 and 0-6 in single lag models. We used the 
lag structure that demonstrated strongest association for each respective outcome in further 
analyses.  
We performed two-pollutant models for pollutants that demonstrated individual associations 
We then conducted stratified analyses of cardiovascular and respiratory mortality according 
to previous hospitalizations. Furthermore, we investigated difference in risk by sex, age, and 
seasons using interaction terms. Age was dichotomized by the median at the time of cause-
specific death of individuals with respective previous hospitalisations.  Season was divided 
into cold (October to March) and warm (April to September) season. 
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3.2.2 Studies III and IV 
3.2.2.1 Case-crossover  
In studies III and IV, the case-crossover analysis with time-stratified referent strategy was 
used to analyze the association between transient exposure to air pollution and OHCA. The 
case-crossover design was developed to study the effects of transient exposure on acute 
health outcomes. In this design, the period immediately preceding the event time is 
considered the case period and other specified time intervals other than the case period are the 
control periods. The advantage of case-crossover design is it allows the patients to serve as 
their own controls thus slowly changing personal characteristics are controlled for.   
In studies III and IV, models were adjusted for relative humidity and temperature. We used 
the same averaging periods as for exposure, however, for 2-h air pollution averages we used 
24-h averages. In study III, we modelled temperature as piece-wise linear spline with a knot 
at the temperature threshold (12 oC) that was observed as the 24-h temperature associated 
with the lowermost OR for OHCA [88]. In study IV, temperature was modelled as a 
restricted cubic spline with 2 df. Relative humidity was modelled as a linear term in both 
studies.  
3.2.2.2 Conditional logistic regression 
In studies III and IV, we used conditional logistic regression. This statistical method is mainly 
used when a study participant identified as a case regarding the particular condition, 
treatment, or attribute of a study is matched with study participants acting as controls without 
that condition, treatment, or attribute. This method is used to test the probability of an event 
to occur while controlling for other covariates.  
3.2.2.3 Statistical analyses 
In study III, we used 2-h, 24-h, and 72-h means as our exposure periods for all air pollutants 
and 8-h maximum O3 was calculated within the previous 24-h.  
We first analyzed associations between short-term exposure to air pollution and OHCAs 
using our three exposure windows. For pollutants that demonstrated associations we 
performed two-pollutant models. We performed seasonal analysis for cold (October to 
March) and warm (April to September) season. We modelled temperature as piece wise linear 
with a knot at the lowest risk temperature of 14 oC in winter and 10 oC in summer. We also 
investigated effect modification by sex and age by constructing multiplicative interaction 
terms. Age was categorised as below the median or above including median.  
We performed an interaction analysis between 2-h exposure to air pollution and OHCA by 
event location under the assumption that exposure classification would perform better for 
events that occurred outdoors. Using information available for pick-up location of OHCA, we 
coded events as outdoors if they occurred in the street, taxis, cars, public transport, public 
transport terminals or stations, and in sports facilities. Furthermore, the events occurring at 
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home, workplace, health center, and nursing homes were coded as indoors. Cases for which 
the location of event was specified as other and unclear were coded as unknown. In addition 
to investigate the likelihood that witnessed OHCA would have a better temporal assessment 
of time of OHCA and affect our associations, we performed an interaction analysis using 
information on witnessed or unwitnessed cases.  
For study IV, we used 2-h and 24-h averages and 8-h maximum O3 was calculated in the same 
manner as in study III. 
We included all OHCA that occurred within 100 km radius of the monitoring station. First, 
we performed analysis using 2-h and 24-h averages for all our air pollutants and limited our 
further analyses to the averaging period that demonstrated the clearest association in terms of 
a combination of the largest point estimate and narrowest CI. We then proceeded with two-
pollutant models for pollutants that demonstrated individual effects. We explored difference 
in risk by i) age, dichotomized by median age at the time of OHCA; ii) sex; iii) seasons, 
categorized into cold (October to March) and warm (April to September) season; and vi) 
previous hospitalizations, dichotomized by previous hospitalizations, for instance for heart 
failure or no previous hospitalizations for heart failure. For all effect modification analyses 
we constructed multiplicative terms.  
The estimates are expressed as percent increase or relative difference in risk of death or as 
odds ratios (OR) with 95% confidence intervals (CIs) per 10 µg/m3 increase in air pollution 
levels. Data management, descriptive statistics and main analysis in study II, III, and IV were 
performed using Stata, while in study I statistical software R was used.  
3.3 ETHICAL PERMITS 
All studies have been approved by Regional Ethical Review Board. Reference number for 
studies I and II is 20091919-31/1 and for studies III and IV 2009/1524-32.  
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4 RESULTS 
The studies included in this thesis investigated the role of previous hospitalizations on four 
outcomes i.e total mortality, cardiovascular mortality, respiratory mortality, and OHCA in 
relation to O3 exposure. The first two studies were focused on total, cardiovascular, and 
respiratory mortality and last two studies were focused on OHCA, and results are presented 
following the same order. 
4.1 SHORT-TERM EXPOSURE TO OZONE AND TOTAL, CARDIOVASCULAR, 
AND RESPIRATORY MORTALITY IN INDIVIDUALS WITH AND WITHOUT 
PREVIOUS DISEASES 
4.1.1 Study Populations  
4.1.1.1 Total mortality 
From 1990 to 2010, there were 302,283 total deaths in Stockholm County with an average of 
39 deaths per day. Deaths in women were slightly more than half of the total deaths. Out of 
196,916 individuals with previous hospitalizations for CVD, about 18 % individuals had 
previous hospitalizations for AMI and about 30 % individuals had previous hospitalizations 
for heart failure. There were around 10 % individuals with previous hospitalizations for 
dysrhythmia (Table 4.1).   
4.1.1.2 Cardiovascular mortality 
The average age at the time of death by cardiovascular disease was 77 years in men and 84 
years in women. Fifteen percent had been previously hospitalized for AMI (Table 4.1). 
Among individuals that had not been previously hospitalized for AMI, hospitalization for 
other CVD constituted 44%. Four percent had prior admissions for respiratory diseases after 
excluding individuals with previous hospitalization for AMI and other CVD. Of the 
remaining individuals, <1% had previous hospitalizations for diabetes. Twelve percent of all 
cardiovascular deaths included individuals who had not been hospitalized for any disease 
during the 3 years immediately preceding death. Five percent of the individuals who died in 
CVD had never been admitted to hospital for any disease since the start of the inpatient 
registry in 1987 and were more likely to be men and on average younger than previously 
hospitalized participants.  
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4.1.2 Exposure Characteristics 
In Stockholm County, during our study period average levels of all measured pollutants were 
below WHO AQG. Ozone measurements demonstrated a near-normal distribution with 
sizable variability whereas other pollutants showed right-skewed distributions (Table 4.2) 
Table 4.2 Distribution of air pollution concentrations and meteorological parameters in 2 
day (lag 0-1) and 7 day average (lag 0-6), Stockholm, Sweden, 1990–2010 
  
2 day average 
 
7 day average 
Parameters Mean  
(SD) 
 
 Percentile IQR 
Mean  
(SD) 
 
Percentile IQR 
  5th 95th   5th 95th  
O3 62.8 (20) 31.3  97.1 27.7 62.7 (18)     34.0 93.4 27.0 
PM2.5 8.2 (5)  3.3    18.5 4.6 8.2 (4) 4.0 16.3 3.9 
PM10 15.3 (8) 6.4    32.3 8.8 15.3 (7) 7.7 29.3 7.4 
NO2 19.0 (9) 7.4    34.6 11.3 19.1 (7) 9.2 32.0 9.3 
NOx 26.9 (19) 8.4 60.3 18.3 27.1 (15)     11.0 54.0 16.3 
Temp 7.6 (8) -5    20.0 12.3 - - - - 
Rh 74.7 (12) 50.1       92.2 17.7 - - - - 
         
 
O3, ozone, based on daily 8-hour max values; PM2.5, mass concentration of particles ≤ 2.5 µm in 
aerodynamic diameter; PM10, mass concentration of particles ≤ 10 µm in aerodynamic diameter; NOx, 
nitrogen oxides; NO2, nitrogen dioxide; Temp, temperature; Rh, relative humidity 

4.1.3 Associations Between Ozone and Total Mortality 
In study I, we observed that individuals with and without previous hospitalizations 
demonstrated a 0.5% higher mortality per 10 µg/m3 increase in 0-1 day average of 8-hour 
maximum O3 concentrations (Figure 4.1). In two-pollutant model, the association between O3 
and mortality became stronger on addition of NO2, PM2.5 and PM10 in the model, except for 
NOx where the association remained similar (Figure 4.2).  
Furthermore, individuals with previous hospitalizations for AMI demonstrated a stronger 
association (1.72% increased risk per 10 µg/m3; 95% CI: 0.44%, 3.02%) between O3 
exposure and mortality, three times higher risk than for those with no previous 
hospitalizations for AMI. Moreover, O3 in the warm season showed stronger associations 
with total mortality in these individuals (2.47%, 95% CI: 0.54%, 4.43%). However, 
individuals with previous hospitalizations for heart failure, dysrhythmia, and any other non-
AMI CVD did not demonstrate an increased susceptibility to O3 exposure in relation to total 
mortality (Figure 4.3).  
We further categorized time lapse between hospitalizations for individuals with previous 
AMI hospitalizations and date of death to investigate the temporal influence of previous 
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hospitalizations on the risk of O3-related death. We observed that hospitalizations for AMI 
from 29 days to two years before death was important in influencing the association between 
O3 and total mortality compared to very recent (< 29 days before death) or older (> two years 
before death) previous AMI hospitalizations.  
 
 Figure 4.1 Percent change (95 % confidence interval) in total mortality, cardiovascular 
mortality, and respiratory mortality associated with a 10 µg/m3 increase in 2 day, 2 day, and 7 
day average of 8-hour maximum O3 concentrations, respectively, Stockholm, 1990-2010 
 
We observed a tendency of stronger associations between O3 and total mortality in oldest age 
group of 85+ (2.1%, 95% CI: −0.0%,4.2%) compared with the middle age (71–85 years) 
category (1.1%, 95% CI: −0.73%, 3.0%). Furthermore, younger individuals (<71 years of 
age) also had an indication of higher risk (3.3%, 95% CI: 0.39%, 6.3%) of mortality 
following higher O3 levels compared with the middle age category of individuals, however 
the difference was not significant.    
We did not observe differences in O3-related risk of total mortality between men (2.1%, 95% 
CI: 0.68%, 3.5%) and women (1.4%, 95% CI: −0.07%, 2.8%; interaction p-value = 0.4). 
4.1.4 Associations Between Ozone and Cardiovascular Mortality 
We observed associations between 8-h maximum O3 levels and cardiovascular mortality for 
both averaging periods. Effect estimates were larger and confidence intervals were narrower 
for 2 day averaged 8-h maximum O3 levels before death (0.8 % increased risk per 10 µg/m3; 
95% CI: 0.2%, 1.4%), in comparison with 7 day averaged exposure (Table 4.3). In two-
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pollutant models, association between O3 and cardiovascular mortality remained robust to the 
inclusions of NO2, and NOx in the model, while with PM2.5 estimates became non-significant. 
With PM10 in the model, the estimate for O3 became slightly stronger (1.0 % increased risk 
per 10 µg/m3; 95% CI 0.3%, 1.7%) but an unexpectedly decrease in the risk of CV mortality 
related to PM10 (-1.2%; 95% CI: -2.3%, -0.1%, per 10 µg/m3 increment) was observed (Figure 
4.2).  
 
 
Figure 4.2 Percent change (95 % confidence interval) in total mortality, cardiovascular 
mortality, and respiratory mortality associated with a 10 µg/m3 increase in 2 day, 2 day, and 7 
day average of 8-hour maximum O3 concentrations, respectively, in two-pollutant model 
 
Individuals with previous AMI hospitalizations demonstrated 2.1% higher cardiovascular 
mortality (95% CI 0.51%, 3.8%) per 10 µg/m3 increment of 0-1 day average 8-hr maximum 
O3 (Figure 4.3). No significant associations were observed between O3 exposure and 
cardiovascular death in individuals with prior hospitalizations for CVD excluding AMI, 
respiratory diseases, diabetes or any other disease. We observed associations between O3 and 
cardiovascular deaths in individuals who had not been hospitalized between 0 to 3 years 
before cardiovascular death and who had never been hospitalized since 1987. The magnitudes 
of effect estimates were similar to individuals with prior AMI admissions for both of these 
categories of individuals. 
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Among individuals who had prior hospitalizations for AMI we observed a higher risk of 
cardiovascular death per 10 µg/m3 increment of 0-1 day average 8-hr maximum O3 in 
individuals older than the median age (82 years; 4.2%; 95% CI: 2.5%, 6.3%) compared with 
individuals equal to or below the median age (0.11%, CIs: -1.7%, 1.9%). We observed an 
indication of higher susceptibility in women (3.0%, CIs: 1.2%, 4.8%) compared to men 
(1.3%, CIs: -0.45%, 3.1%). Season did not seem to influence the association between O3 
exposure and cardiovascular mortality.  
4.1.5  Associations Between Ozone and Respiratory Mortality 
We observed a 2.7% higher risk of respiratory death per 10 µg/m3 higher 0-6 day average O3 
levels (Figure 4.1). Estimates were lower for 0-1 day average O3 and respiratory death (Table 
4.3). In two-pollutant models in the co-presence of PM10, NO2, and NOx, the association 
between O3 exposure and respiratory mortality remained strong and significant (Figure 4.2). 
In a two-pollutant model including 0-6 lag O3 and PM2.5, we observed a weaker estimate 
(0.26%, 95% CI: -0.00%, 0.52%) for O3 while the estimate for PM2.5 did not change (-4.3%, 
95% CI: -9.2%, 0.94 %). 
 
Figure 4.3 Percent change (95 % confidence interval) in total, cardiovascular, and respiratory 
mortality associated with a 10 µg/m3 increase in 2 day, 2 day, and 7 day average of 8-hour 
maximum O3 concentrations, respectively. Stratified by previous hospitalizations categories 
and absence of any hospitalization between 0 to 3 years, or since 1987. All strata are mutually 
exclusive except for total mortality. 
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The results of associations between 7 day O3 and respiratory mortality by categories of 
hospitalization demonstrated positive associations (5.5% increased risk per 10 µg/m3 95% CI: 
0.9%, 10%) in individuals with previous COPD hospitalizations (Figure 4.3). We did not 
observe significant associations between O3 exposure and respiratory death in individuals 
with prior hospitalizations for pneumonia, for respiratory diseases excluding COPD and 
pneumonia or for any other disease. 
In further exploratory analyses associations between 7 day average O3 and respiratory 
mortality in individuals with previous COPD hospitalizations remained unchanged in models 
including a multiplicative term for O3 and sex, age, or season 
4.1.6 Associations Between Other Pollutants and Total and 
Cardiorespiratory Mortality 
No associations were observed between average PM2.5, PM10, NO2, and NOx levels and total, 
cardiovascular or respiratory mortality (Table 4.3). 
Table 4.3 Percent change in cardiovascular and respiratory mortality in all subjects 
associated with a 10 µg/m3 increase in 7 day and 2 day average 8-hour maximum O3 
concentrations, respectively. 
 
Pollutant 
 
Averaging 
period 
 
Cardiovascular Mortality 
 
Respiratory Mortality 
  Percent 
change 
95 % CI Percent 
change 
95 % CI 
O3 01 day lag 0.8 (0.2, 1.4) 1.4 (0.06, 2.7) 
 0-6 day lag 0.7 (0.02, 1.5) 2.7 (1.2, 4.3) 
PM2.5 01 day lag -0.7 (-2.8, 1.5) -0.2 (-4.3, 4.1) 
 0-6 day lag -1.2 (-3.8, 1.4) -4.0 (-8.9, 1.1) 
PM10 01 day lag -0.9 (-2.0, 0.2) 0.04 (-2.2, 2.3) 
 0-6 day lag -1.0 (-2.4, 0.4) -0.8 (-3.6, 2.2) 
NOx 01 day lag -0.1 (-0.5, 0.4) 0.3 (-0.6, 1.2) 
 0-6 day lag 0.02 (-0.6, 0.7) -0.1 (-1.5, 1.3) 
NO2 01 day lag -0.7 (-1.8, 0.4) 0.3 (-2.1, 2.7) 
 0-6 day lag 0.3 (-1.2, 1.8) -0.1 (-4.4, 2.1) 
      
 
O3, ozone, based on daily 8-hour max values; PM2.5, mass concentration of particles ≤ 2.5 µm in 
aerodynamic diameter; PM10, mass concentration of particles ≤ 10 µm in aerodynamic diameter; NOx, 
nitrogen oxides; NO2, nitrogen dioxide 
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4.2 SHORT-TERM EXPOSURE TO OZONE AND OUT-OF-HOSPITAL CARDIAC 
ARREST: SUSCEPTIBILITY BY PREVIOUS DISEASES 
4.2.1 Study Populations 
In study III, we included 5,973 OHCA that occurred in Stockholm County from 2000 to 
2010. A majority of OHCAs occurred in men (67%). The average age at the time of OHCA 
was 74 in women and 70 in men. About two-thirds of the OHCA occurred at home (Table 
4.4).  
The time period for study IV was from 2006 to 2014 and total of 11,923 EMS-assessed 
OHCAs were included from Stockholm County, Gothenburg, and Malmö. About 90% of the 
OHCAs occurred indoors. A majority of OHCAs occurred in men and the average age at the 
time of OHCAs in women was 69 years and 72 years in men. About 16% of the individuals 
had previous hospitalizations for AMI. Arrhythmias (24%), dominated by atrial fibrillation, 
were the most commonly occurring diagnoses of previous hospitalization in the individuals 
who had OHCA. Percentages of hospitalizations for stroke (2.5 %) and hypertension (3.3 %) 
were low. Individuals with previous hospitalizations were six percent. Forty-four percent of 
the individuals had been hospitalized due to any disease three or more times since 1987. 
There were 21% of the individuals who had no hospitalization for any disease before OHCA 
(Table 4.4). 
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4.2.2 Exposure Characteristics 
Air pollution levels were generally lower in Gothenburg and Stockholm compared to Malmö 
(Table 4.5). The difference in air pollution levels for 2 and 24-h case and control periods was 
very small in both study settings and time periods. 
4.2.3 Associations Between Ozone and Out-of-Hospital Cardiac Arrest 
In study III, we observed positive associations between O3 and OHCAs in both 2- and 24-h 
averages, with a higher estimate for the latter (Figure 4.4). Study IV, confirmed this 
association (Table 4.5).  Further in study III, in a distributed lag model for 24-h lags from lag-
0 to lag-6, the lag-0 demonstrated an independent association between O3 and OHCAs. For 
the cumulative 3 day average of O3 exposure, we observed an OR of 1.05 (95% CI: 1.01, 
1.09) for a 10 mg/m3 increase. In two pollutant models, the association between O3 and 
OHCA remained unchanged in the co-presence of particulate matter, while on addition of 
NO2 in the model CIs spanned null.   
 
Figure 4.4 Associations of 2-hour and 24-hour exposure to air pollutants with OHCA per 10 
µg/m3 in Stockholm from 2000 to 2010, adjusted for temperature and relative humidity. 
Our results demonstrated an indication of stronger associations in the cold season (OR: 1.05; 
CI: 1.01 – 1.10) compared with the warm season (OR: 1.01; CI: 0.97–1.05; interaction P-
value = 0.1) in 24-h O3 exposure window. We also performed analysis based on the location 
of OHCAs and observed stronger association between O3 and OHCAs in events occurring 
outdoors (OR: 1.13; 95 % CI: 1.05 – 1.21) compared with the events that occurred indoors 
(OR: 1.02; 95 % CI: 0.99 – 1.05) for 2-h exposure. In interaction analyses by age, gender, or 
witnessed events we did not observe differences in association between 24-h average O3 
levels and OHCA (age = 0.9, interaction P-value; gender = 0.4, witnessed = 0.4)
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4.2.4 Other Pollutants 
Neither in study III nor in study IV were associations observed between PM2.5, PM10, coarse 
particles, NO2, and NOx and OHCAs in all exposure averages (Figure 4.4 and Table 4.6). 
Table 4.6. Pooled Analysis. Associations of 2-h and 24-h exposure to air pollutants with out-
of-hospital cardiac arrest from 2006-2014, per 10 µg/m3   
 
Pollutant 
(µg/m3) 
 
Moving average 
(h) 
 
OR 
 
95% CI 
O3 2-h 1.02 (1.00, 1.03) 
 24-h 1.02  (1.00, 1.04) 
 8-h max 1.01  (1.00, 1.03) 
PM2.5 2-h 0.97  (0.94, 1.01) 
 24-h 0. 97  (0.93, 1.01) 
PM10 2-h 0.99  (0.96, 1.01) 
 24-h 0.96 (0.93, 0.99) 
NO2 2-h 0.98 (0.96, 0.99) 
 24-h 0.97  (0.94, 1.00) 
    
 
O3, ozone; PM2.5, mass concentration of particles ≤ 2.5 µm in aerodynamic diameter; PM10, mass 
concentration of particles ≤ 10 µm in aerodynamic diameter; NO2, nitrogen dioxide:  
 
4.2.5 Susceptibility to Ozone-Related Risk of OHCA by Previous Diseases 
We did not observe any difference in higher 2-h average O3 exposure and the risk of OHCA 
between individuals with or without previous hospitalizations for any disease based on the p-
value for interaction and strata specific results (Figure 4.5). In addition, we did not observe a 
difference in risk of OHCA following 2-h average O3 exposure in individuals hospitalized for 
any of the pre-specified diagnoses of AMI, heart failure, diabetes, hypertension or stroke (all 
p-values for interaction > 0.05) except for arrhythmias where we found evidence of 
interaction. Common for all strata-specific results, ORs for individuals with previous 
hospitalizations were below or near the null whereas the comparison group reflected results 
found in the overall study population.  In the case of individuals previously hospitalized for 
arrhythmias, results indicated a counter-intuitively lower risk of OHCA with higher exposure 
to O3. 
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Figure 4.5 Pooled Analysis. Odds ratios for out-of-hospital cardiac arrest per 10 µg/m3 higher 
2-hour average of O3 concentrations by previous hospitalizations for any disease, acute 
myocardial infarction, heart failure, arrhythmias, diabetes, hypertension, and stroke. 
 
 
 
 
 
 
 
 
 
P=0.15
P=0.14
P=0.00
P=0.06
P=0.06
P=0.64
P=0.7No
 Yes
No
Yes
No
 Yes
No
Yes
No 
Yes
No
 Yes
not hospitalized
Yes
 Stroke 
Hypertension
Diabetes
Arrhythmias
Heart Failure
Acute Myocardial Infarction
For any disease
Pr
ev
iou
s H
os
pit
ali
za
tio
ns
.94 .97 .99 1 1.02 1.04 1.06
Odds ratio (95% CI)
 34 
5 DISCUSSION 
We observed associations between short-term exposure to elevated urban background O3 
concentrations and the increased risk of total, cardiovascular and respiratory mortality and 
OHCA. Individuals who had been previously hospitalized for acute myocardial infarction had 
an increased risk of O3-related mortality, both total and cardiovascular, in comparison to 
overall population. Higher O3-related risk of cardiovascular mortality was also observed in 
individuals with out-of-hospital cardiovascular death as their first manifestation of an 
underlying disease. Furthermore, individuals who had previous hospitalizations for COPD 
had an increased risk of O3-related respiratory mortality. However, we did not observe 
previous diseases to confer susceptibility to higher O3 levels and the risk of OHCA.  
5.1 OZONE EXPOSURE AND MORTALITY 
This thesis adds to the existing literature demonstrating associations between transient O3 
exposure and total mortality as well as with cardiovascular mortality and respiratory 
mortality. Our results of association between O3 exposure and total mortality are consistent 
with the large meta-analyses [72, 89] performed on the US and non-US cities which reported 
a 20 µg/m3 increase of daily O3 at 2 day average increased the risk of death by 0.87% (95% 
CIs, 0.55%, 1.18%). The Air Pollution and Health a European Approach (APHEA2) project 
consisting of 23 European cities also observed increase in total deaths per 10 µg/m3 increase 
in the 1-hour O3 concentrations (0.3%, 95% CIs: 0.17-0.52) and similar estimates were 
observed for 8-h maximum O3. Similarly, several single [63, 90] and multicity studies [33, 
91-97], and meta-analyses [72, 98] within and outside Europe have reported consistent 
significant associations between O3 and cardiovascular mortality. On the contrary, respiratory 
mortality has been inconsistently associated with O3 in all year analysis but stronger 
consistent significant associations were reported during the warm period of the year [63, 90, 
93, 94, 98]. 
For cardiovascular mortality, we observed similar associations in both averaging periods (2 
day and 7 day) of 8-hr maximum O3. In contrast, higher estimates were observed for the 
association between 7 day average 8-hr maximum O3 and respiratory mortality compared to 
the shorter averaging period of 2 day. This pattern is largely consistent with the APHEA 
study that also reported stronger estimates for the association between O3 and respiratory 
mortality in longer lags (0-20 day) as compared to shorter lags (0 and 0-1 day), while the 
opposite was observed for cardiovascular mortality [93]. This implies that exposure to high 
O3 levels has a more immediate effect on triggering cardiovascular mortality, whereas the 
effect on respiratory mortality might require longer O3 exposure and other biological 
processes [93].  
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5.1.1 Risk with Previous Hospitalizations 
5.1.1.1 Acute myocardial infarction 
Some research has been conducted on identifying individuals susceptible to the harmful 
effects of O3 based on previous CVD, however, our results are generally concordant with 
results from the existing studies. In our study I [24], we observed higher risk of death in 
association with 8-hr maximum O3 exposure in individuals with previous AMI compared to 
the full study population. In study II, where we investigated cardiovascular mortality, we 
observed higher risk estimates than in study I (1,7% vs 2.1%) in individuals with previous 
hospitalizations for AMI that may be in part be explained by a more specific outcome. A 
study from Italy [33], investigating total mortality, reported non-significant associations 
between 0-5 day 8-hr maximum O3 and total mortality in individuals with previous AMI 
hospitalizations (2.6% increase risk per 10 µg/m3 (95% CIs: -1.0%, 6.4%). Another study 
from Italy [69] investigating a more specific outcome, reported a borderline significant 
association between O3 exposure and out-of-hospital coronary deaths in individuals who had 
previous hospitalizations for ischemic heart disease, which lends some support to our finding 
of increased susceptibility to cardiovascular mortality in individuals with previous 
hospitalizations for AMI. In contrast to our results, a large multicity study from the US using 
secondary cause of death as a proxy for pre-existing disease reported no increased 
susceptibility between O3 and mortality for atherosclerotic conditions, however additional 
susceptibility was observed for atrial fibrillation [70]. 
5.1.1.2 Heart failure 
In our study, we did not observe associations between O3 exposure and total mortality in 
individuals with previous hospitalizations for heart failure. Other studies were also unable to 
report conferred susceptibility by previous hospitalization for heart failure for O3-related risk 
of death [33, 69, 70]. A plausible explanation for the absence of association could be that 
these individuals are elderly and might have multiple comorbidities, which limits their 
outdoor movement and physical activity, leading to more time spent indoors and less 
exposure to O3.  
5.1.1.3 Diabetes 
Previous studies have suggested diabetes as a susceptible condition for air pollution-related 
cardiovascular events [50, 99], and a study from Italy [33] reported diabetes as the pre-
existing condition that conferred susceptibility to O3-associated mortality. Results of other 
studies, including our study, point the same direction but with poor precision [69, 70]. 
5.1.1.4 Chronic obstructive pulmonary disease 
Chronic obstructive pulmonary disease, is a progressive irreversible airflow limitation and 
chronic inflammation of the lungs, and is the fourth leading cause of death worldwide [100]. 
The disease represents heavy economic burden and costs are largely associated with disease 
exacerbations which lead to emergency department visits, hospitalizations, and death. Ozone 
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exposure has been consistently associated with respiratory mortality in previous studies [63, 
90, 93, 94, 98]. Studies include several large multi-city studies, and associations have 
generally been reported from exposure periods between 0-1 and 0-5 day lags, and our 
estimate of 2.7 higher risk per 10 µg/m3 0-6 day exposure is roughly in line with previously 
reported estimates. In addition to studies investigating O3 exposure and respiratory mortality, 
several studies have observed associations between O3 exposure and hospital admission for 
COPD [79-81, 101, 102]. Few previous studies have investigated the role of previous 
hospitalizations for respiratory diseases on association between O3 exposure and respiratory 
mortality. None of these have reported increased risk of death in individuals with previous 
respiratory hospitalizations [33, 69, 70]. In our further exploratory analyses of these 
individuals with previous hospitalizations for COPD, we observed no evidence to support 
different susceptibility to O3 by age and sex. Also, our seasonal analyses did not demonstrate 
influence of seasons on association between O3 and respiratory mortality in individuals with 
COPD, while the previous studies have demonstrated stronger associations for the warm 
period of the year between O3 exposure and respiratory mortality [29, 33, 93, 94] irrespective 
of previous hospitalizations. 
5.1.2 Risk without Previous Hospitalizations 
Out-of-hospital cardiovascular deaths with no previous hospitalization for any causes 
demonstrated a strong association with O3 exposure. It is likely that many of these individuals 
had underlying condition that made them susceptible to O3 exposure, but that this condition 
had not been subject to hospital care. General practitioner visits were not available as a 
possible indication of previous disease in our material. Epidemiological studies as well as 
autopsy series reported presence of structural heart disease, including coronary artery disease, 
in 50-95% of adults who suffered sudden cardiac death without previously known heart 
disease [103, 104]. Cardiovascular death in individuals not hospitalized since 1987 were 
relatively younger (mean age 73 years) compared to the rest of the individuals. Younger 
individuals are more likely to be exposed to higher O3 levels through outdoor physical 
activity. These results lead to study III where we hypothesized that exposure to higher short-
term O3 levels increase the risk of OHCA [105].  
5.2 OZONE AND OUT-OF-HOSPITAL CARDIAC ARREST 
The results of our study demonstrated associations between transient exposure to O3 and 
OHCA in a smaller sample from Stockholm [105] and in a large pooled dataset from 
Gothenburg, Malmö, and Stockholm. These results are consistent with some [49, 73-75] but 
not all studies [42, 44, 48, 82-85, 106]. Other studies have also observed independent 
associations of both O3 and PM2.5 with OHCA [44, 49, 75, 105] in contrast to our study 
where we did not observe associations for PM2.5. Our results indicated a near instantaneous 
association of O3 exposure with OHCA and were robust to the inclusion of PM10 or PM2.5, 
suggesting independent associations of O3 with OHCA. Studies from Houston, Helsinki, and 
France have also investigated short averaging time windows for exposure [73-75]. However, 
only our study and the Houston study reported associations between O3 exposure and OHCA 
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in hourly averages while others reported delayed effects. The magnitude of our associations 
between 24-hr average O3 and risk of OHCA are in line with results from a recently 
published meta-analysis (OR of 1.01; 95% CIs: 1.00,1.02 versus our result OR 1.02; 95% 
CIs:1.00, 1.04 per 10 µg/m3) [107].  
5.2.1 Susceptibility by Previous Hospitalizations to Ozone-Related OHCA 
Pre-existing conditions such as diabetes and cardiovascular diseases including myocardial 
infarction, heart failure, diabetes, hypertension, rhythm disorders and stroke have been 
associated with increased risk of OHCA [108-110]. A study on out-of-hospital coronary 
events [69] reported higher risks of events following higher O3 levels, in individuals with 
previous hospitalizations for cerebrovascular diseases and artery diseases. Previous studies 
[48, 49] reported higher susceptibility to OHCA following PM2.5 exposure in individuals with 
previous disease history for diabetes, hypertension, and stroke. However, previously no study 
has investigated the possible effect modification of the association between O3 and OHCA by 
previous manifestation of cardiovascular disease.  
Our study did not demonstrate previous hospitalizations conferring susceptibility to O3 
exposure in relation to OHCA. Indeed, we observed no difference in risk of OHCA on 
exposure to O3 between individuals with or without previous hospitalization for any disease 
and we did not observe any higher risk among individuals previously hospitalized for AMI, 
heart failure, arrhythmias, diabetes, hypertension or stroke. Some of the discrepancies 
between our study and other studies [24, 33, 69] are likely explained by different outcomes 
investigated (although some overlap is expected), the temporal resolution of the event or 
exposure, or model specifications between time-series and case-crossover design. 
Furthermore, differences in O3 estimates between different studies partly reflect variations in 
total O3 exposure resulting from the variations in the amount of outdoor O3 permeating 
indoors [111], and the amount of time spent indoors [112]. Ozone is highly reactive and 
removed by indoor surfaces [113], therefore, measures based on outdoor monitors may be an 
inadequate marker of capturing personal O3 exposure [78]. In Sweden, buildings are 
comparatively tight with limited air exchange rates, which keeps the median indoor O3 levels 
around 10 µg/m3 [114], remarkably lower than mean outdoor O3 levels (median 51 µg/m3).  
Furthermore, it is plausible that individuals with the same underlying condition in different 
populations might have different medical treatment and management, which turn may confer 
differences in their risk from ambient air pollution. There are however no epidemiological or 
clinical studies to support this argument [115]. 
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5.3 EFFECT MODIFICATION BY AGE AND SEX 
5.3.1 Difference in Risk of Ozone-Related Death in Individuals with Previous 
AMI Hospitalization  
We identified elderly with previous AMI hospitalizations as high-risk groups in both studies I 
and II. Elderly have been consistently reported as susceptible to the detrimental effects of O3 
exposure [24, 33, 57, 69]. In contrast, findings on O3 related mortality risk difference by sex 
are inconsistent. We observed a tendency of higher risk of cardiovascular mortality in women 
with previously hospitalizations for AMI, consistent with a majority of studies that have 
reported stronger associations between O3 exposure and cardiovascular outcomes in women 
[33, 70], although some inconsistencies remain [24] and studies investigating specific 
pathophysiological mechanisms are lacking [70].  
5.3.2 Difference in Risk of OHCA 
We did not observe risk differences by age and sex. In contrast, other studies have 
consistently reported elderly as susceptible to harmful effects of O3 exposure on OHCA [49, 
74, 76]. Comparatively, differences in associations between O3 and OHCA by sex are 
inconsistent [73-76, 105]. 
5.4 SEASONAL INFLUENCE OF OZONE 
Ozone has a high temporal variation with peaks on sunny days during the spring and summer 
in Sweden. Indoor sources of O3 are very few and due to its highly reactive nature it reacts 
with the indoor surface which further reduces indoor O3 exposure, in particular during the 
heating season when Swedish houses tend to be more closed. Thus, O3 exposure mostly 
occurs outdoors only, especially in the winter period. A majority of studies have reported 
higher risks of O3-related total, cardiovascular, and respiratory mortality in summer seasons 
[27, 33, 70, 93, 94], however, in our studies we did not observe a clear influence of seasons 
on risk of death in individuals with previous AMI hospitalizations.  
Furthermore, among studies investigating associations between OHCA and air pollution 
exposure only one study from Houston reported stronger associations during the warm season 
[73] whereas other studies either reported no difference [75, 76, 105] or an indication of 
higher risks during cold season [49, 75]. We may speculate that study-specific differences in 
seasonal results may reflect behavioral differences related to climate and time spent indoors. 
5.5 POSSIBLE BIOLOGICAL MECHANISMS 
Inflammation and oxidative stress are integral components in the pathogenic process of 
COPD [116] but also in that of atherosclerotic heart disease [117].  Ozone has a high 
oxidative potential and produce respiratory inflammation that may hinder recovery from 
infections, or may generate systemic responses. Animal studies have shown that O3 adversely 
react with airway epithelium, inducing smooth muscle hyperplasia and dysfunction, and to 
contribute to subsequent bronchial hyperresponsiveness [118]. Panel studies on healthy 
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young individuals observed that O3 exposure was associated with increase in levels of 
inflammatory markers such as pro-inflammatory cytokines and C-reactive protein, 
plasminogen activator inhibitor 1, fibrinogen, and 8-hydroxy-2′-deoxyguanosine, reduced 
lung function, and decreased heart rate variability [119-122]. Ozone exposure has also been 
associated with alterations in the autonomic nervous system [77, 123-126] and changes in 
blood pressure in individuals with [127] and without [128] previous cardiovascular disease. 
Several other mechanisms, like arterial pressure control, coagulation, thrombosis, vascular 
tone, and oxidative stress have also been associated with O3 exposure [57, 128] supporting a 
likely association with cardiovascular mortality. Furthermore, these association were 
observed soon before the measurement consistent with the effects of O3 on mortality largely 
in few days of exposure [93].   
5.6 METHODOLOGICAL CONSIDERATIONS 
In epidemiology, research often relies on data collected for other purposes and even if 
collected for your particular study aim, it is unlikely to be free of errors. People live 
complicated lives and epidemiologists need to reduce that complexity, and thus no 
epidemiological study can be free of errors. The challenge is to carry out a study with an aim 
to minimize error to the greatest extent possible and be able to assess the effects of 
unavoidable errors. An important aspect of epidemiology is to be able to recognize likely 
sources of errors and, essentially, to assess the potential effects of those errors on your work 
[129]. In the following sections I discussed the challenges we faced while performing studies 
included in this thesis. 
5.6.1 Exposure Assessment 
The aim of short-term exposure assessment in air pollution studies is to obtain an exposure 
estimate as representative as possible to the true individual air pollution exposure. The ideal 
situation would be to measure personal exposure which represents exposure outdoors and 
indoors; however, it is impractical for large studies with rare events like mortality. Instead 
time-series of continuous exposure measurements from strategically located fixed air 
pollution monitoring stations are used. Similar to other studies of ambient air pollution we 
relied on data from fixed monitors in each city to estimate exposure instead of individual 
monitoring of air pollution exposure. We had a high coverage of hourly measurements of air 
pollution data minimizing the risk of temporal misclassification. In study IV, we restricted 
our study areas to 100 km radius of monitoring station and further restriction to 50 km in 
sensitivity analyses resulted in similar results for all pollutants. The underlying assumption is 
that variability in short-term individual exposure in part is described by the variability of the 
concentrations at the fixed monitoring sites. In Stockholm County we have one regional and 
several local monitoring stations and all pollutant measurements from all stations were highly 
correlated and exhibited temporal compared to spatial variability in short-exposure windows 
(Figure 5.1 and Figure 5.2). 
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Figure 5.1 Hourly O3 concentrations on randomly selected days in the same year from 
regional and local monitoring stations in Stockholm County  
 
Figure 5.2 Hourly PM2.5 concentrations on randomly selected days in the same year from 
regional and local monitoring stations in Stockholm County 
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Data on long-term exposure to O3 was not available, furthermore, we did not have a data 
regarding time spent indoors, activity pattern, and location of residents, that could decrease 
the exposure misclassification; however, this type of misclassification is likely non-
differential and therefore underestimate observed associations [130]. However, we cannot 
exclude some bias.  
5.6.2 Outcome Assessment 
All outcome data for all our studies were collected from registers. The quality of register data 
is dependent on the physician’s assigned diagnosis.  Furthermore, the accuracy of diagnosis 
will depend to some extent on the disease manifestation and varies with primary and 
secondary diagnoses. For instance, diagnosis for AMI and stroke is slightly more precise in 
the Swedish hospital discharge register than for heart failure [131]. In addition, heart failure 
as a primary diagnosis has a validity of 95% vs 75% when listed as a secondary cause of 
hospitalization [131].  
The strength of the Swedish Cause of Death and Inpatient registries is their full coverage and 
high validity [132]. As discussed earlier some level of inaccuracy is expected in the registry 
data, it is not, however, expected to vary with our exposure and thus the net result would be 
an underestimation of the observed estimates.  
We benefitted from a large sample of a well-defined outcome with etiologic data of OHCA 
and highly accurate information concerning handling times provided by Swedish Register for 
Cardiopulmonary Resuscitation [133]. The wide-coverage of the register also reduced the risk 
of selection bias.  
5.6.3 Confounding Control 
The research question addressed in studies I and II was whether short-term variation in O3 
levels was related to mortality. Our exposure and outcome data have seasonal patterns as well 
as long-term trends and day of week effects. It is necessary to control for these potentially 
joint temporal patterns in order to separate them from short-term associations between O3 
exposure and mortality [134]. We went through a rigorous process of selecting statistical 
models for confounding control of seasonal patterns and long-term trends with the aim to 
arrive at a bias-free model to estimate associations. Generally in epidemiology age, sex, 
biomass index, socioeconomic status, smoking status, and so on, are common confounders 
but these confounders are not applicable in our studies as they do not fluctuate on daily basis 
and therefore cannot be associated with variations neither in ambient O3 levels nor in short-
term variations in mortality risk. Potential confounders in short-term air pollution studies are 
entities with short-term fluctuations and possible relations to short-term changes in O3 and 
mortality [134]. Ozone and temperature are strongly correlated and temperature has been 
associated with mortality [135] and also exacerbate physiological responses to short-
term exposure to O3 [136]. Therefore, appropriate control for temperature while assessing 
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effects of O3 is crucial. In our study setting, O3 and temperature were moderately correlated.  
We adjusted our final models using restricted cubic spline with 4 df, allowing a high degree 
of flexibility.  We performed several analyses using 2 day, 7 day, and 14 day for temperature 
adjustments and we also excluded 99th and 95th percentiles but nothing affected our results, 
indicating that the confounding control in our final model was adequate.   
In studies III and IV, we used a time stratified case-crossover study design [137]. This design 
allows cases to serve their own controls, thus, time invariant individuals characteristics are 
taken care of by the design (as in time-series analysis with Poisson regression). We selected 
controls periods on same time of the day, same day of the month, and within the same 
calendar month which allows the design to control for day of week effects, seasonal patterns, 
and to some extent long-term time trends. The potential confounders which vary over time 
are meteorological parameters like temperature and relative humidity. The confounding 
control for these two variables included adding temperature as piece-wise linear spline in 
Study III and as restricted cubic splines with 2 df in study IV and relative humidity was added 
as a linear term in both studies. 
In comparison, case-crossover is easy to implement and seasonal patterns and long-term 
trends in both exposure and outcome are controlled by the design, while time-series requires 
intensive model specifications [138]. Both designs can give equitable estimates of the risk of 
detrimental health outcomes associated with transient exposure to higher levels of ambient 
O3. Both designs, depending on choice of temporal smoothing in time-series design and 
selection of controls in case-crossover design, can be implemented in several different ways 
[138]. However, time-series design is more powerful compared to case-crossover in the sense 
that air pollution exposure on the day of event is compared with the exposure every other day 
in the study period but in case-crossover each case period is compared to a limited number of 
controls periods [139], in our case three or four. Therefore, the estimates based on time-series 
analysis are more precise [138].  
5.6.4 Mortality Displacement 
Mortality displacement is a concept to describe the possibility that deaths associated with 
exposure, for instance to O3, occur mostly in individuals who are terminally ill  and hence the 
effect of O3 is merely to trigger the death slightly ahead of time [93]. In this case, positive 
associations between exposure and daily mortality on days with higher exposure are followed 
by negative associations between exposure and daily mortality on following days with similar 
orders of magnitude [93, 140]. Based on the mortality displacement hypothesis the public 
health significance of short-term air pollution studies has been questioned. A study 
investigating mortality displacement in the association of O3 and mortality in 48 US cities did 
not observe mortality displacement in response to O3, but rather concluded single day 
exposure averages may underestimate the public health impact of O3 [93]. However, 21 
European cities study, APHEA-2, reported an indication of displacement in total and 
cardiovascular mortality, but not for respiratory mortality [94]. In our studies, we did not 
specifically investigate short-term mortality displacement, but we found no evidence of 
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mortality displacement in the time span of 7 days, as estimates for 7 day and 2 day averages 
were similar. 
5.6.5 Mortality or Case-Only Data 
Death or mortality records are the oldest and widely used indicators of health status. Death 
has the advantage of its universality and that in most countries there are strong incentives for 
the authorities to accurately record who dies and when. However, mortality is an incomplete 
measure of health status because it does not consider chronic disease or disease burden and 
only measures the end of disease processes. Furthermore, the cause of death is difficult to 
accurately ascertain and becomes more complicated in case of multiple chronic diseases 
[141]. Our studies included case-only designs for mortality and OHCA and thus precluded 
any interpretation of disease incidence, as well as difference in mortality and OHCA 
incidence between different parts of the population. 
5.7 PUBLIC HEALTH SIGNIFICANCE 
Our findings indicate that individuals with previous history of myocardial infarction and 
chronic obstructive pulmonary disease are especially sensitive to O3 exposure. These results 
support the consideration of increased risk in large susceptible subpopulations in health 
impact assessments of O3 exposure. In Sweden, O3 concentrations are greatly influenced by 
regional and intercontinental transport of O3 and its precursors. Therefore, increased 
protection of public health requires mitigation efforts not only at a local but at a regional 
scale. For a more immediate increase in protections of the general public, forecasting and 
reporting real-time O3 levels, involving media, with precautionary recommended measures 
may be developed. Furthermore, health care providers communicate with at-risk patients and 
precautionary recommendations may limit the health hazards of elevated O3 levels. These 
measures at a local level are practical and feasible and may help to decrease exposure to O3 
and lower the associated respiratory and cardiovascular risk.   
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6 CONCLUSIONS 
Ozone exposure was associated with increased risk of acute mortality and cardiac arrest in a 
Nordic environment with ~ 60 µg/m3 annual 8-h maximum O3 levels and individuals with 
previous disease manifestations showed higher O3-related risks.  
More specifically: 
• Exposure to ambient O3 was associated with increased risk of total, cardiovascular, 
and respiratory mortality within 2-7 days. 
• Previous hospitalization for acute myocardial infarction was associated with an 
increased susceptibility for O3-related total and cardiovascular death.   
• Previous hospitalization for chronic obstructive pulmonary disease was associated 
with an increased susceptibility for O3-related respiratory death.  
• Exposure to ambient O3 was associated with increased risk of out-of-hospital cardiac 
arrest within 2-72 hours but we did not demonstrate higher risks among individuals 
previously hospitalized for cardiovascular disease. 
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7 POPULAR SCIENCE SUMMARY 
7.1 IN SWEDISH 
Luften som vi andas innehåller luftföroreningar från naturligt förekommande källor såväl 
som från olika mänskliga aktiviteter (antropogena källor). Dessa föroreningar är gaser eller 
partiklar som företrädelsevis är så små att de är osynliga för blotta ögat. Naturligt 
förekommande källor inkluderar bland annat vulkanutbrott och olika typer av bränder medan 
de antropogena källorna inkluderar trafik, industri och förbränning av olika bränslen. 
Forskare över hela världen har studerat de negativa effekterna, efter både lång och kort tids 
exponering, av dessa föroreningar på människors hälsa och har observerat effekter på hjärt-
kärlsjukdomar, lungsjukdomar, allergier och till och med på död. 
I min avhandling har jag fokuserat på korttidseffekter av en gasformig luftförorening som 
heter ozon. Högt upp i atmosfären finns det ett ozonlager som hjälper till att skydda oss från 
ultraviolett strålning, men jag har studerat ozon vid marknivå. Det marknära ozonet skapas av 
kemiska reaktioner som involverar lättflyktiga organiska föreningar, som exempelvis metan, i 
närvaro av solljus. Kväveoxider är också involverade i dessa reaktioner. Ozon som skapats i 
en region kan färdas tusentals kilometer och bidra till förhöjda nivåerna långt ifrån där det 
skapats. Flera studier har rapporterat effekter av korttidsexponering för ozon på ökad 
dödlighet, liksom effekter på hjärtstopp utanför sjukhus och flertalet andra sjukdomar. Den 
samlade kunskapen om vilka i en befolkning som har en ökad risk att drabbas av negativa 
hälsoeffekter relaterade till ozon är knapphändig. Det är viktigt att identifiera känsliga 
grupper i befolkningen för att kunna skapa luftkvalitetsstandarder och riktlinjer som också 
skyddar viktiga känsliga grupper.  Med tanke på detta var vår målsättning i den här 
avhandlingen att undersöka vilken roll tidigare sjukdomar har i att påverka den ozon-
relaterade risken för dödlighet överlag, för död i hjärt-kärlsjukdom och för död i 
lungsjukdomar, liksom för risken att drabbas av hjärtstopp utanför sjukhus. För att genomföra 
vår studie inhämtade vi information om samtliga naturliga dödsfall som inträffade i 
Stockholms län mellan 1990 och 2010. Information om alla hjärtstopp utanför sjukhus som 
blev bedömda av sjukvårdspersonal inhämtades från det nationella hjärtstoppsregistret. Vi 
inkluderade alla hjärtstopp utanför sjukhus som inträffade i Stockholms län mellan 2006 och 
2014, samt alla hjärtstopp utanför sjukhus som inträffade mellan 2006 och 2014 i Göteborg 
och Malmö. Med hjälp av personnumret sammanlänkade vi alla dödsfall och hjärtstopp 
utanför sjukhus med tidigare sjukhusinläggningar som registrerats i nationella 
patientregistret. Information om ozonnivåer inhämtades från en mätstation centralt placerad 
ovan tak i varje stad. Vi genomförde sedan en statistisk analys för att utvärdera effekten av 
ozonnivåer på totaldödlighet, hjärt-kärldödlighet och lungdödlighet, samt på hjärtstopp 
utanför sjukhus.  
Våra resultat visade att individer som tidigare varit sjukhusvårdade på grund av en 
hjärtinfarkt eller en allvarlig lungsjukdom hade högre risk att dö jämfört med befolkningen i 
övrigt, efter 2 till 7 dagars exponering av förhöjda nivåer av ozon. I motsatts till detta verkade 
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inte tidigare sjukhusvård för hjärt-kärlsjukdomar påverka effekten av kortidsexponering för 
ökade ozonnivåer och risken för att drabbas av hjärtstopp utanför sjukhus.   
Dessa resultat ger ytterligare stöd till tanken att det finns stora grupper i befolkningen som är 
särskilt känsliga för hälsopåverkan av ozon.  I Sverige påverkas ozonnivåerna mycket av 
regional och interkontinental transport av ozon och de föreningar som bidrar till att ozon 
bildas. Det är därför av vikt att insattser för att förbättra folkhälsan genom minskade utsläpp 
av luftföroreningar inte bara sker på en lokal nivå utan också på en regional nivå. För att 
uppnå en mer direkt skyddande effekt av den generella befolkningen är det möjligt att 
utveckla verktyg i form av prognoser och realtidsrapportering av ozonnivåer som kan komma 
befolkningen till del genom media. Det är också möjligt att utveckla 
försiktighetsrekommendationer för känsliga grupper. Vidare kan vårdgivares kommunikation 
med patienter med en förhöjd risk och förebyggande rekommendationer begränsa de skadliga 
hälsoeffekterna av förhöjda nivåer av ozon. Dessa åtgärder på en lokal nivå är praktiska och 
genomförbara och kan hjälpa till att minska exponeringen för ozon och minska de relaterade 
riskerna för lungsjukdomar och hjärt-kärlsjukdomar. 
7.2 IN ENGLISH 
The air we breathe contains air pollutants from natural and man-made sources. These 
pollutants are gaseous or particles that mostly are so small that they are invisible to naked 
eye. Natural sources include volcanic eruptions and natural fires while the man-made sources 
include traffic, industry, and burning of fuels. Researchers around the globe have studied the 
negative effects, both long-term and short-term, of these pollutants on human health and have 
observed effects on cardiovascular diseases, respiratory illnesses, allergies, and even death.  
In my thesis, I have focused on short-term effects of a gaseous air pollutant called ozone. 
Very high up there is an ozone layer that helps protect us from ultraviolet radiation, but I have 
studied the ozone at ground level. Such ozone is formed by chemical reactions involving 
volatile organic compounds, for example methane, in the presence of sunlight. Nitrogen 
oxides are also involved in these reactions. Ozone formed in one region can travel thousands 
of kilometer to contribute to increased levels far away. Several studies have reported effects 
of short-term ozone exposure on mortality, as well as with out-of-hospital cardiac arrest and 
other disease manifestations. Knowledge on whom among the general population is at higher 
risk of adverse ozone-related health effects is scarce. It is important to identify sensitive 
populations in order to provide guidelines for air quality standards that also protect significant 
sensitive groups within the general population. Therefore, in this thesis we aimed to explore 
the role of previous diseases in modifying the risk of mortality for all diseases, cardiovascular 
diseases, and respiratory diseases, as well as the risk of out-of-hospital cardiac arrests. To 
carry out our study we obtained a data on all natural deaths that occurred in Stockholm 
County from 1990 to 2010. Data on all out-of-hospital cardiac arrests which were assessed by 
emergency staff were obtained from the Swedish Register for Cardiopulmonary 
Resuscitation. We included all out-of-hospital cardiac arrests that occurred in Stockholm 
County from 2000 to 2010, as well as all out-of-hospital cardiac arrest that occurred from 
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2006 to 2014 in Stockholm, Gothenburg and Malmö. We used personal identification 
numbers to link all deaths and out-of-hospital cardiac arrests to their previous hospitalizations 
as recorded in the National Patient Register. Data on ozone was obtained from a single 
monitoring station in each city. We then performed statistical analyses on our data to assess 
effects of ozone levels on total, cardiovascular and respiratory deaths, and OHCA. 
Our results showed that individuals who have been previously hospitalized due to a heart 
attack or to severe lung diseases are at a higher risk of death as compared to general 
population after 2 to 7 days exposure to increased ozone levels. In contrast, previous 
hospitalizations for cardiovascular diseases did not appear to change the effect of short-term 
exposure to elevated ozone concentrations on the risk out-of-hospital cardiac arrest.  
These results support the consideration of increased risk in large susceptible subpopulations 
in health impact assessments of ozone exposure. In Sweden, ozone concentrations are greatly 
influenced by regional and intercontinental transport of ozone and its precursors. Therefore, 
increased protection of public health requires mitigation efforts not only at a local but at a 
regional scale. For a more immediate increase in protections of the general public, forecasting 
and reporting real-time ozone levels, involving media, with precautionary recommended 
measures may be developed. Furthermore, health care providers communicate with at-risk 
patients and precautionary recommendations may limit the health hazards of elevated ozone 
levels. These measures at a local level are practical and feasible and may help to decrease 
exposure to ozone and lower the associated respiratory and cardiovascular risk.   
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